Bloem Ada E M, Dolk Hanneke M, Wind Anne E, van der Vis Joanne J, Kampen Maarten J, Custers Jan W H, Spruit Martijn A, Veltkamp Marcel
Institute of Movement Studies, Faculty of Health Care, University of Applied Sciences Utrecht, Utrecht, the Netherlands; Department of Pulmonology, St. Antonius Hospital, Interstitial Lung Diseases Center of Excellence, Member of European Reference Network-Lung, Nieuwegein, the Netherlands.
Department of Pulmonology, St. Antonius Hospital, Interstitial Lung Diseases Center of Excellence, Member of European Reference Network-Lung, Nieuwegein, the Netherlands.
Respir Med. 2025 Jan;236:107862. doi: 10.1016/j.rmed.2024.107862. Epub 2024 Nov 20.
Idiopathic pulmonary fibrosis (IPF) is a fatal progressive fibrosing lung disease. A decreased 6-min walk distance (6MWD) and exercise-induced oxygen desaturation measured during the 6-min walk test (6MWT), are known predictors of mortality in patients with IPF. However, the use of antifibrotic drugs showed a survival benefit in IPF. Therefore, this study aimed to evaluate to what extend 6MWT-derived attributes are associated with two-year survival when antifibrotic drugs were introduced as part of standard IPF-care.
This real-world data-study included patients with IPF with a 6MWT between 2015 and 2020, and used composite outcome: mortality or lung transplantation within 2 years of follow-up. Data were collected systematically, including demographics, pulmonary function tests, comorbidities, medications and 6MWT-derived attributes. The prediction attributes of 6MWT were studied with a Cox Proportional-Hazards model and Kaplan-Meier survival curves. The best discriminating attribute to predict mortality was added to the prediction model Gender-Age-Physiology (GAP).
In 216 patients, 2-year transplant-free survival cut-off points were identified for the 6MWD (≥413 m), 6MWD %predicted (≥83 %), SpO-nadir (≥86 %) and distance-saturation-product (≥374 m%), with the best discriminative value for SpO-nadir (area under the curve: 0.761). 2-Year survival percentage of patients with SpO-nadir below or above threshold (86 %) was 37.1 % and 80.0 %, respectively. Exercise-induced oxygen desaturation added to the GAP model showed an improvement in its predictive power.
Patients with IPF who have an exercise-induced oxygen desaturation have worse prognosis. Addition of SpO-nadir to the GAP model seems promising for use in clinical care of IPF patients.
特发性肺纤维化(IPF)是一种致命的进行性纤维化肺部疾病。6分钟步行距离(6MWD)缩短以及在6分钟步行试验(6MWT)期间测得的运动性氧饱和度下降是IPF患者死亡率的已知预测指标。然而,使用抗纤维化药物显示对IPF患者有生存益处。因此,本研究旨在评估在将抗纤维化药物作为IPF标准治疗的一部分引入时,6MWT衍生的指标与两年生存率的关联程度。
这项真实世界数据研究纳入了2015年至2020年间进行6MWT的IPF患者,并使用复合结局:随访2年内的死亡率或肺移植。系统收集数据,包括人口统计学、肺功能测试、合并症、药物治疗以及6MWT衍生的指标。使用Cox比例风险模型和Kaplan-Meier生存曲线研究6MWT的预测指标。将预测死亡率的最佳区分指标添加到预测模型性别-年龄-生理学(GAP)中。
在216例患者中,确定了6MWD(≥413米)、预测的6MWD百分比(≥83%)、最低血氧饱和度(SpO- nadir,≥86%)和距离-饱和度乘积(≥374米%)的2年无移植生存切点,其中最低血氧饱和度的区分价值最佳(曲线下面积:0.761)。最低血氧饱和度低于或高于阈值(86%)的患者2年生存率分别为37.1%和80.0%。添加到GAP模型中的运动性氧饱和度下降显示其预测能力有所提高。
有运动性氧饱和度下降的IPF患者预后较差。将最低血氧饱和度添加到GAP模型中似乎有望用于IPF患者的临床护理。